Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Holders of 5% or more of CRBP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Corbus Pharmaceuticals Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 13G/A | 13.36%2.34M shares | +0.54 ppfrom 12.82% | Mar 18, 20244 filings | Dec 15, 2025 | SEC |
| Standard Life Aberdeen plc | 13G | 7.53%1.32M shares | New | Jan 16, 20261 filing | Jan 16, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.90%1.09M shares | +3.00 ppfrom 2.90% | Oct 22, 20244 filings | Jul 27, 2026 | SEC |
| OrbiMed Advisors LLC | 13G/A | 5.90%718.2K shares | – | Nov 14, 20242 filings | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
46 Schedule 13D and 13G filings on Corbus Pharmaceuticals Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:02 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 1.10%206.4K shares | −4.20 ppfrom 5.30%Below 5% | Jun 30, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G | 5.90%1.09M shares | +3.00 ppfrom 2.90% | Jun 30, 2026 | SEC |
| May 14, 20264:01 PM ET | Octagon Capital Advisors LPand 2 others | 13G/A | 0.00%0 shares | −5.40 ppfrom 5.40%Below 5% | Mar 31, 2026 | SEC |
| Feb 10, 20261:14 PM ET | Octagon Capital Advisors LPand 2 others | 13G/A | 5.40%955.0K shares | – | Dec 31, 2025 | SEC |
| Jan 16, 20269:59 AM ET | Standard Life Aberdeen plcand 1 other | 13G | 7.53%1.32M shares | New | Dec 31, 2025 | SEC |
| Dec 15, 20254:19 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 13.36%2.34M shares | +0.54 ppfrom 12.82% | Dec 11, 2025 | SEC |
| Nov 14, 20251:23 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 12.82%2.38M shares | – | Nov 3, 2025 | SEC |
| Nov 12, 20254:24 PM ET | Citadel Advisors LLCand 6 others | 13G | 5.30%980.6K shares | New | Nov 4, 2025 | SEC |
| Jul 29, 202511:26 AM ET | Vanguard Group Inc | 13G/A | 4.89%599.5K shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 2.90%352.4K shares | –Below 5% | Jun 30, 2025 | SEC |
| Feb 14, 20254:30 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 5.90%718.2K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Tang Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | K2 HealthVentures Equity Trust LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | OrbiMed Advisors LLC | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Adage Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Oct 15, 2024 | Millennium Management LLC | 13G/AOld format | – | – | – | SEC |
| Oct 11, 2024 | Octagon Capital Advisors LP | 13GOld format | – | New | – | SEC |
| Mar 18, 2024 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 28, 2024 | Millennium Management LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | K2 HealthVentures Equity Trust LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | K2 HealthVentures Equity Trust LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Paradigm Biocapital Advisors LP | 13GOld format | – | – | – | SEC |
| Feb 12, 2024 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 12, 2024 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Feb 5, 2024 | Paradigm Biocapital Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 5, 2024 | Cormorant Global Healthcare Master Fund, LP | 13GOld format | – | New | – | SEC |
| Jan 29, 2024 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Jan 26, 2024 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| Aug 24, 2022 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Jun 1, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| May 11, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Apr 9, 20216:02 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Mar 17, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 28, 20215:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 11, 2021 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2021 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Corbus Pharmaceuticals Holdings, Inc. shares.
No Form 144 notices for Corbus Pharmaceuticals Holdings, Inc. are on file.